The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Treatment of Inflammatory Bowel Disease: A Comprehensive Review
Open accessAbstract
Inflammatory bowel disease (IBD), as a global disease, has attracted much research interest. Constant research has led to a better understanding of the disease condition and further promoted its management. We here reviewed the conventional and the novel drugs and therapies, as well as the potential ones, which have shown promise in preclinical studies and are likely to be effective future therapies. The conventional treatments aim at controlling symptoms through pharmacotherapy, including aminosalicylates, corticosteroids, immunomodulators, and biologics, with other general measures and/or surgical resection if necessary. However, a considerable fraction of patients do not respond to available treatments or lose response, which calls for new therapeutic strategies. Diverse therapeutic options are emerging, involving small molecules, apheresis therapy, improved intestinal microecology, cell therapy, and exosome therapy. In addition, patient education partly upgrades the efficacy of IBD treatment. Recent advances in the management of IBD have led to a paradigm shift in the treatment goals, from targeting symptom-free daily life to shooting for mucosal healing. In this review, the latest progress in IBD treatment is summarized to understand the advantages, pitfalls, and research prospects of different drugs and therapies and to provide a basis for the clinical decision and further research of IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,531
Organoid Models and Applications in Biomedical Research
Xinaris, C., Brizi, V., & Remuzzi, G. (2015) · Nephron · doi:10.1159/000433566 · Cited by 3,515
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
Present, D. H., Rutgeerts, P., Targan, S., Hanauer, S. B., Mayer, L., van Hogezand, R. A., Podolsky, D. K., Sands, B. E., Braakman, T., DeWoody, K. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905063401804 · Cited by 2,752
Designing and developing a literature-derived, population-based dietary inflammatory index
Shivappa, N., Steck, S. E., Hurley, T. G., Hussey, J. R., & Hébert, J. R. (2014) · Public Health Nutrition · doi:10.1017/s1368980013002115 · Cited by 2,731
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Regulation of immune responses by extracellular vesicles
Robbins, P. D., & Morelli, A. E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3622 · Cited by 2,260
Gomollón, F., Dignass, A., Annese, V., Tilg, H., Van Assche, G., Lindsay, J. O., Peyrin-Biroulet, L., Cullen, G. J., Daperno, M., Kucharzik, T., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw168 · Cited by 2,057
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Feagan, B. G., Sandborn, W. J., Gasink, C., Jacobstein, D., Lang, Y., Friedman, J. R., Blank, M. A., Johanns, J., Gao, L.-L., Miao, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602773 · Cited by 1,845
Predictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,820
Immunomodulatory properties of mesenchymal stromal cells
Nauta, A. J., & Fibbe, W. E. (2007) · Blood · doi:10.1182/blood-2007-02-069716 · Cited by 1,788
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Su, C., Sands, B. E., D’Haens, G. R., Vermeire, S., Schreiber, S., Danese, S., Feagan, B. G., Reinisch, W., Niezychowski, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606910 · Cited by 1,770
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
Lichtiger, S., Present, D. H., Kornbluth, A., Gelernt, I., Bauer, J., Galler, G., Michelassi, F., & Hanauer, S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302601 · Cited by 1,714
Dignass, A., Lindsay, J. O., Sturm, A., Windsor, A., Colombel, J.-F., Allez, M., D'Haens, G., D'Hoore, A., Mantzaris, G., Novacek, G., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.002 · Cited by 1,548
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control
Clevers, H., Loh, K. M., & Nusse, R. (2014) · Science · doi:10.1126/science.1248012 · Cited by 1,364
Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Fölsch, U. R., Timmis, K. N., & Schreiber, S. (2004) · Gut · doi:10.1136/gut.2003.025403 · Cited by 1,311
Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276
KINO, T., HATANAKA, H., MIYATA, S., INAMURA, N., NISHIYAMA, M., YAJIMA, T., GOTO, T., OKUHARA, M., KOHSAKA, M., AOKI, H., et al. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1256 · Cited by 1,209
Harbord, M., Eliakim, R., Bettenworth, D., Karmiris, K., Katsanos, K., Kopylov, U., Kucharzik, T., Molnár, T., Raine, T., Sebastian, S., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx009 · Cited by 1,180
Growing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and Applications
Sato, T., & Clevers, H. (2013) · Science · doi:10.1126/science.1234852 · Cited by 1,170
Janus kinases in immune cell signaling
Ghoreschi, K., Laurence, A., & O’Shea, J. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00754.x · Cited by 1,149 · cited 1×
“They interact with the common gamma chain subunit of six cytokine receptors (IL2, IL-4, IL-7, IL-9, IL-15, and IL-21) that have a crucial role in lymphopoiesis and homeostasis (112).”
BackgroundPostbiotics: An Evolving Term within the Functional Foods Field
Aguilar-Toalá, J. E., Garcia-Varela, R., Garcia, H. S., Mata-Haro, V., González-Córdova, A. F., Vallejo-Cordoba, B., & Hernández-Mendoza, A. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.03.009 · Cited by 1,078
Hou, J. K., Abraham, B., & El-Serag, H. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.44 · Cited by 1,009
Panaccione, R., Ghosh, S., Middleton, S., Márquez, J. R., Scott, B. B., Flint, L., van Hoogstraten, H. J. F., Chen, A. C., Zheng, H., Danese, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.052 · Cited by 963
Bovine milk-derived exosomes for drug delivery
Munagala, R., Aqil, F., Jeyabalan, J., & Gupta, R. C. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.10.020 · Cited by 931
Rossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., Löwenberg, M., van den Brink, G. R., Mathus-Vliegen, E. M. H., de Vos, W. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.045 · Cited by 921
Aggarwal, B. B., Gupta, S. C., & Kim, J. H. (2012) · Blood · doi:10.1182/blood-2011-04-325225 · Cited by 877
Costello, S. P., Hughes, P. A., Waters, O., Bryant, R. V., Vincent, A. D., Blatchford, P., Katsikeros, R., Makanyanga, J., Campaniello, M. A., Mavrangelos, C., et al. (2019) · JAMA · doi:10.1001/jama.2018.20046 · Cited by 842
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Colombel, J.-F., Sands, B. E., Rutgeerts, P., Sandborn, W., Danese, S., D'Haens, G., Panaccione, R., Loftus, E. V., Sankoh, S., Fox, I., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-311079 · Cited by 806
Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell
Yui, S., Nakamura, T., Sato, T., Nemoto, Y., Mizutani, T., Zheng, X., Ichinose, S., Nagaishi, T., Okamoto, R., Tsuchiya, K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2695 · Cited by 805
Sandborn, W. J., Feagan, B. G., Marano, C., Zhang, H., Strauss, R., Johanns, J., Adedokun, O. J., Guzzo, C., Colombel, J., Reinisch, W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.06.010 · Cited by 727
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
Feagan, B. G., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Koval, J., Wong, C. J., Hopkins, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422202 · Cited by 727
Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis
Gonzalez-Rey, E., Anderson, P., González, M. A., Rico, L., Büscher, D., & Delgado, M. (2009) · Gut · doi:10.1136/gut.2008.168534 · Cited by 677
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
Schnitzler, F., Fidder, H., Ferrante, M., Noman, M., Arijs, I., Van Assche, G., Hoffman, I., Van Steen, K., Vermeire, S., & Rutgeerts, P. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20927 · Cited by 673
Baranyai, T., Herczeg, K., Onódi, Z., Voszka, I., Módos, K., Marton, N., Nagy, G., Mäger, I., Wood, M. J., El Andaloussi, S., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145686 · Cited by 670
González, M. A., Gonzalez–Rey, E., Rico, L., Büscher, D., & Delgado, M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.11.041 · Cited by 631
Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA · doi:10.1001/jama.2014.13875 · Cited by 629
Duijvestein, M., Vos, A. C. W., Roelofs, H., Wildenberg, M. E., Wendrich, B. B., Verspaget, H. W., Kooy-Winkelaar, E. M. C., Koning, F., Zwaginga, J. J., Fidder, H. H., et al. (2010) · Gut · doi:10.1136/gut.2010.215152 · Cited by 622
Quraishi, M. N., Widlak, M., Bhala, N., Moore, D., Price, M., Sharma, N., & Iqbal, T. H. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14201 · Cited by 617
Kao, D., Roach, B., Silva, M., Beck, P., Rioux, K., Kaplan, G. G., Chang, H.-J., Coward, S., Goodman, K. J., Xu, H., et al. (2017) · JAMA · doi:10.1001/jama.2017.17077 · Cited by 615
Colorectal cancer prevention in ulcerative colitis: a case‐control study
Eaden, Abrams, Ekbom, Jackson, & Mayberry (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00698.x · Cited by 577
Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-analysis
Khan, K. J., Ullman, T. A., Ford, A. C., Abreu, M. T., Abadir, A., Marshall, J. K., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.72 · Cited by 569
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Feagan, B. G., D’Haens, G., Wolf, D. C., Jovanovic, I., Hanauer, S. B., Ghosh, S., Petersen, A., Hua, S. Y., Lee, J. H., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2033617 · Cited by 569
Hébert, J. R., Shivappa, N., Wirth, M. D., Hussey, J. R., & Hurley, T. G. (2019) · Advances in Nutrition · doi:10.1093/advances/nmy071 · Cited by 552
VanDussen, K. L., Marinshaw, J. M., Shaikh, N., Miyoshi, H., Moon, C., Tarr, P. I., Ciorba, M. A., & Stappenbeck, T. S. (2015) · Gut · doi:10.1136/gutjnl-2013-306651 · Cited by 525
Adipose-derived and bone marrow mesenchymal stem cells: A donor-matched comparison
Mohamed-Ahmed, S., Fristad, I., Lie, S. A., Suliman, S., Mustafa, K., Vindenes, H., & Idris, S. B. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0914-1 · Cited by 515
Paramsothy, S., Nielsen, S., Kamm, M. A., Deshpande, N. P., Faith, J. J., Clemente, J. C., Paramsothy, R., Walsh, A. J., van den Bogaerde, J., Samuel, D., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.001 · Cited by 512
Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.
Connell, W. R., Kamm, M. A., Ritchie, J. K., & Lennard-Jones, J. E. (1993) · Gut · doi:10.1136/gut.34.8.1081 · Cited by 510
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
Wang, Y., Parker, C. E., Bhanji, T., Feagan, B. G., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000543.pub4 · Cited by 494
Shaw, S. Y., Blanchard, J. F., & Bernstein, C. N. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.398 · Cited by 483
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
Sandborn, W. J., Rutgeerts, P., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Lu, J., Horgan, K., Rachmilewitz, D., Hanauer, S. B., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.061 · Cited by 473
A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis
Ogata, H., Matsui, T., Nakamura, M., Iida, M., Takazoe, M., Suzuki, Y., & Hibi, T. (2006) · Gut · doi:10.1136/gut.2005.081794 · Cited by 462
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
Vermeire, S., O'Byrne, S., Keir, M., Williams, M., Lu, T. T., Mansfield, J. C., Lamb, C. A., Feagan, B. G., Panes, J., Salas, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60661-9 · Cited by 452
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
Sandborn, W. J., Feagan, B. G., Wolf, D. C., D’Haens, G., Vermeire, S., Hanauer, S. B., Ghosh, S., Smith, H., Cravets, M., Frohna, P. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513248 · Cited by 452
Feagan, B. G., Sandborn, W. J., D'Haens, G., Panés, J., Kaser, A., Ferrante, M., Louis, E., Franchimont, D., Dewit, O., Seidler, U., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30570-6 · Cited by 451
Van Assche, G., D’haens, G., Noman, M., Vermeire, S., Hiele, M., Asnong, K., Arts, J., D’hoore, A., Penninckx, F., & Rutgeerts, P. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01214-9 · Cited by 448
Vermeire, S., Schreiber, S., Petryka, R., Kuehbacher, T., Hebuterne, X., Roblin, X., Klopocka, M., Goldis, A., Wisniewska-Jarosinska, M., Baranovsky, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32537-5 · Cited by 439
Paramsothy, S., Paramsothy, R., Rubin, D. T., Kamm, M. A., Kaakoush, N. O., Mitchell, H. M., & Castaño-Rodríguez, N. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx063 · Cited by 436
Optimizing anti-TNF treatments in inflammatory bowel disease
Ben-Horin, S., Kopylov, U., & Chowers, Y. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.06.002 · Cited by 419
Lichtenstein, G. R., Abreu, M. T., Cohen, R., & Tremaine, W. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.048 · Cited by 417
Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease
Monteleone, G., Neurath, M. F., Ardizzone, S., Di Sabatino, A., Fantini, M. C., Castiglione, F., Scribano, M. L., Armuzzi, A., Caprioli, F., Sturniolo, G. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407250 · Cited by 401
Systematic review with meta-analysis: The efficacy of probiotics in inflammatory bowel disease
Derwa, Y., Gracie, D. J., Hamlin, P. J., & Ford, A. C. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14203 · Cited by 393
Cox, S. R., Lindsay, J. O., Fromentin, S., Stagg, A. J., McCarthy, N. E., Galleron, N., Ibraim, S. B., Roume, H., Levenez, F., Pons, N., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.09.024 · Cited by 382
Diet in the Pathogenesis and Treatment of Inflammatory Bowel Diseases
Lee, D., Albenberg, L., Compher, C., Baldassano, R., Piccoli, D., Lewis, J. D., & Wu, G. D. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.007 · Cited by 379
Yan, F., Cao, H., Cover, T. L., Washington, M. K., Shi, Y., Liu, L., Chaturvedi, R., Peek, R. M., Wilson, K. T., & Polk, D. B. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44031 · Cited by 375
Diet as a Trigger or Therapy for Inflammatory Bowel Diseases
Lewis, J. D., & Abreu, M. T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.019 · Cited by 375
Tsilingiri, K., Barbosa, T., Penna, G., Caprioli, F., Sonzogni, A., Viale, G., & Rescigno, M. (2012) · Gut · doi:10.1136/gutjnl-2011-300971 · Cited by 364
Leoni, G., Neumann, P.-A., Kamaly, N., Quiros, M., Nishio, H., Jones, H. R., Sumagin, R., Hilgarth, R. S., Alam, A., Fredman, G., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76693 · Cited by 354
ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease
Bischoff, S. C., Escher, J., Hébuterne, X., Kłęk, S., Krznaric, Z., Schneider, S., Shamir, R., Stardelova, K., Wierdsma, N., Wiskin, A. E., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.002 · Cited by 351
Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease
Nielsen, O. H., & Ainsworth, M. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmct1209614 · Cited by 334
Forbes, G. M., Sturm, M. J., Leong, R. W., Sparrow, M. P., Segarajasingam, D., Cummins, A. G., Phillips, M., & Herrmann, R. P. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.06.021 · Cited by 333
Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Ford, A. C., Bernstein, C. N., Khan, K. J., Abreu, M. T., Marshall, J. K., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.70 · Cited by 328
Identification of exosome-like nanoparticle-derived microRNAs from 11 edible fruits and vegetables
Xiao, J., Feng, S., Wang, X., Long, K., Luo, Y., Wang, Y., Ma, J., Tang, Q., Jin, L., Li, X., et al. (2018) · PeerJ · doi:10.7717/peerj.5186 · Cited by 325
Ganji‐Arjenaki, M., & Rafieian‐Kopaei, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25911 · Cited by 314
Vermeire, S., Joossens, M., Verbeke, K., Wang, J., Machiels, K., Sabino, J., Ferrante, M., Van Assche, G., Rutgeerts, P., & Raes, J. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv203 · Cited by 311
New targets for mucosal healing and therapy in inflammatory bowel diseases
Neurath, M. F. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.73 · Cited by 309
Middendorp, S., Schneeberger, K., Wiegerinck, C. L., Mokry, M., Akkerman, R. D. L., Wijngaarden, S., Clevers, H., & Nieuwenhuis, E. E. S. (2014) · STEM CELLS · doi:10.1002/stem.1655 · Cited by 305
Herreros, M. D., Garcia-Arranz, M., Guadalajara, H., De-La-Quintana, P., & Garcia-Olmo, D. (2012) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e318255364a · Cited by 303
Food, immunity, and the microbiome
Tilg, H., & Moschen, A. R. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.036 · Cited by 292
Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn Disease
Wang, K., Zhang, H., Kugathasan, S., Annese, V., Bradfield, J. P., Russell, R. K., Sleiman, P. M. A., Imielinski, M., Glessner, J., Hou, C., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.01.026 · Cited by 291
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
Akobeng, A. K., Zhang, D., Gordon, M., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003715.pub3 · Cited by 289
Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis
Sandborn, W. J., Ghosh, S., Panes, J., Schreiber, S., D’Haens, G., Tanida, S., Siffledeen, J., Enejosa, J., Zhou, W., Othman, A. A., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.030 · Cited by 289
An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab
Wyant, T., Fedyk, E., & Abhyankar, B. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw092 · Cited by 284
Colombel, J.-F., D’haens, G., Lee, W.-J., Petersson, J., & Panaccione, R. (2020) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjz131 · Cited by 283
Effects of glucocorticoids on gene transcription
Hayashi, R., Wada, H., Ito, K., & Adcock, I. M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.011 · Cited by 277
Anti-TNF Therapy in Crohn’s Disease
Adegbola, S. O., Sahnan, K., Warusavitarne, J., Hart, A., & Tozer, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082244 · Cited by 274
Travis, S. P. L., Danese, S., Kupcinskas, L., Alexeeva, O., D'Haens, G., Gibson, P. R., Moro, L., Jones, R., Ballard, E. D., Masure, J., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-304258 · Cited by 262
Sala, E., Genua, M., Petti, L., Anselmo, A., Arena, V., Cibella, J., Zanotti, L., D’Alessio, S., Scaldaferri, F., Luca, G., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.013 · Cited by 248
Micronutrient deficiencies in inflammatory bowel disease
Weisshof, R., & Chermesh, I. (2015) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000226 · Cited by 245
Staley, C., Hamilton, M. J., Vaughn, B. P., Graiziger, C. T., Newman, K. M., Kabage, A. J., Sadowsky, M. J., & Khoruts, A. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.6 · Cited by 244
Nguyen, L. H., Örtqvist, A. K., Cao, Y., Simon, T. G., Roelstraete, B., Song, M., Joshi, A. D., Staller, K., Chan, A. T., Khalili, H., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30267-3 · Cited by 244
Mao, F., Wu, Y., Tang, X., Kang, J., Zhang, B., Yan, Y., Qian, H., Zhang, X., & Xu, W. (2017) · BioMed Research International · doi:10.1155/2017/5356760 · Cited by 241
Aminosalicylates for induction of remission or response in Crohn's disease
Lim, W.-C., Wang, Y., MacDonald, J. K., & Hanauer, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008870.pub2 · Cited by 239
IL-23: a master regulator in Crohn disease
Neurath, M. F. (2007) · Nature Medicine · doi:10.1038/nm0107-26 · Cited by 239
Breast milk-derived exosomes promote intestinal epithelial cell growth
Hock, A., Miyake, H., Li, B., Lee, C., Ermini, L., Koike, Y., Chen, Y., Määttänen, P., Zani, A., & Pierro, A. (2017) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2017.01.032 · Cited by 239
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis
Sandborn, W. J., Peyrin-Biroulet, L., Zhang, J., Chiorean, M., Vermeire, S., Lee, S. D., Kühbacher, T., Yacyshyn, B., Cabell, C. H., Naik, S. U., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.10.035 · Cited by 235
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis
Sandborn, W. J., Ferrante, M., Bhandari, B. R., Berliba, E., Feagan, B. G., Hibi, T., Tuttle, J. L., Klekotka, P., Friedrich, S., Durante, M., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.08.043 · Cited by 229
5-Aminosalicylates and renal function in inflammatory bowel disease: A systematic review
Gisbert, J. P., González-Lama, Y., & Maté, J. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20099 · Cited by 220
Liu, H., Liang, Z., Wang, F., Zhou, C., Zheng, X., Hu, T., He, X., Wu, X., & Lan, P. (2019) · JCI Insight · doi:10.1172/jci.insight.131273 · Cited by 220
Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
GISBERT, J. P., LINARES, P. M., MCNICHOLL, A. G., MATÉ, J., & GOMOLLÓN, F. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04023.x · Cited by 218
Exosome‐mediated effects and applications in inflammatory bowel disease
Ocansey, D. K. W., Zhang, L., Wang, Y., Yan, Y., Qian, H., Zhang, X., Xu, W., & Mao, F. (2020) · Biological Reviews · doi:10.1111/brv.12608 · Cited by 209
Bjarnason, I., Sission, G., & Hayee, B. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00595-4 · Cited by 208
Probiotics for induction of remission in Crohn's disease
Limketkai, B. N., Akobeng, A. K., Gordon, M., & Adepoju, A. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006634.pub3 · Cited by 203
Eichenberger, R. M., Ryan, S., Jones, L., Buitrago, G., Polster, R., Montes de Oca, M., Zuvelek, J., Giacomin, P. R., Dent, L. A., Engwerda, C. R., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00850 · Cited by 197
Comparative effects of six probiotic strains on immune function in vitro
Dong, H., Rowland, I., & Yaqoob, P. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511005824 · Cited by 197
Zhang, X.-F., Guan, X.-X., Tang, Y.-J., Sun, J.-F., Wang, X.-K., Wang, W.-D., & Fan, J.-M. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02503-5 · Cited by 193
Yılmaz, İ., Dolar, M. E., & Özpınar, H. (2019) · Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.18227 · Cited by 193
Hawkey, C. J., Allez, M., Clark, M. M., Labopin, M., Lindsay, J. O., Ricart, E., Rogler, G., Rovira, M., Satsangi, J., Danese, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.16700 · Cited by 189
Vermeire, S., Sandborn, W. J., Danese, S., Hébuterne, X., Salzberg, B. A., Klopocka, M., Tarabar, D., Vanasek, T., Greguš, M., Hellstern, P. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30930-3 · Cited by 188
Probiotics for induction of remission in ulcerative colitis
Kaur, L., Gordon, M. A., Baines, P. A., Iheozor‐Ejiofor, Z., Sinopoulou, V., & Akobeng, A. K. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005573.pub3 · Cited by 187
Saccharomyces boulardii Does Not Prevent Relapse of Crohn's Disease
Bourreille, A., Cadiot, G., Le Dreau, G., Laharie, D., Beaugerie, L., Dupas, J., Marteau, P., Rampal, P., Moyse, D., Saleh, A., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.021 · Cited by 186
Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn’s Disease
Rutgeerts, P., Gasink, C., Chan, D., Lang, Y., Pollack, P., Colombel, J.-F., Wolf, D. C., Jacobstein, D., Johanns, J., Szapary, P., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.035 · Cited by 184
Baumgart, D. C., Pintoffl, J. P., Sturm, A., Wiedenmann, B., & Dignass, A. U. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00524.x · Cited by 182
Xiao, G.-Y., Cheng, C.-C., Chiang, Y.-S., Cheng, W. T.-K., Liu, I.-H., & Wu, S.-C. (2016) · Scientific Reports · doi:10.1038/srep23120 · Cited by 182
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study
Feagan, B. G., Panés, J., Ferrante, M., Kaser, A., D’Haens, G., Sandborn, W. J., Louis, E. J., Neurath, M. F., Franchimont, D. P., Dewit, O., et al. (2018) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(18)30233-4 · Cited by 180
Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
Waljee, A. K., Wiitala, W. L., Govani, S., Stidham, R., Saini, S., Hou, J., Feagins, L. A., Khan, N., Good, C. B., Vijan, S., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158017 · Cited by 176
Dietary interventions for induction and maintenance of remission in inflammatory bowel disease
Limketkai, B. N., Iheozor-Ejiofor, Z., Gjuladin-Hellon, T., Parian, A., Matarese, L. E., Bracewell, K., MacDonald, J. K., Gordon, M., & Mullin, G. E. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012839.pub2 · Cited by 171
Exosome-Induced Regulation in Inflammatory Bowel Disease
Zhang, H., Wang, L., Li, C., Yu, Y., Yi, Y., Wang, J., & Chen, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01464 · Cited by 171
Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041623 · Cited by 171
New treatment options for inflammatory bowel diseases
Verstockt, B., Ferrante, M., Vermeire, S., & Van Assche, G. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1449-z · Cited by 170
Avoidance of Fiber Is Associated With Greater Risk of Crohn’s Disease Flare in a 6-Month Period
Brotherton, C., Martin, C., Long, M. D., Kappelman, M. D., & Sandler, R. S. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.029 · Cited by 165
Response of Refractory Colitis to Intravenous or Oral Tacrolimus (FK506)
Fellermann, K., Tanko, Z., Herrlinger, K. R., Witthoeft, T., Homann, N., Bruening, A., Ludwig, D., & Stange, E. F. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200209000-00002 · Cited by 160
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares
Albenberg, L. G., Brensinger, C. M., Wu, Q., Gilroy, E. D., Kappelman, M. D., Sandler, R. S., & Lewis, J. D. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.015 · Cited by 156
Mardini, H. E., & Grigorian, A. Y. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000084 · Cited by 155
European trial of cyclosporine in chronic active Crohn's disease: A 12-month study
Stange, E. F., Modigliani, R., Peña, A. S., Wood, A. J., Feutren, G., & Smith, P. R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90384-4 · Cited by 152
The emerging role of histologic disease activity assessment in ulcerative colitis
Pai, R. K., Jairath, V., Casteele, N. V., Rieder, F., Parker, C. E., & Lauwers, G. Y. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.08.018 · Cited by 152
Yoshimatsu, Y., Yamada, A., Furukawa, R., Sono, K., Osamura, A., Nakamura, K., Aoki, H., Tsuda, Y., Hosoe, N., Takada, N., et al. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i19.5985 · Cited by 150
Planat‐Benard, V., Varin, A., & Casteilla, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.626755 · Cited by 149
Brassard, P., Bitton, A., Suissa, A., Sinyavskaya, L., Patenaude, V., & Suissa, S. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.313 · Cited by 147
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
Murray, A., Nguyen, T. M., Parker, C. E., Feagan, B. G., & MacDonald, J. K. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000543.pub5 · Cited by 147
Review article: smoking cessation as primary therapy to modify the course of Crohn's disease
Johnson, G., Cosnes, J., & Mansfield, J. C. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02424.x · Cited by 146
Yoshimura, N., Watanabe, M., Motoya, S., Tominaga, K., Matsuoka, K., Iwakiri, R., Watanabe, K., & Hibi∥, T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.044 · Cited by 145
Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications
Pasquali, S., & Gronchi, A. (2017) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834017705588 · Cited by 143
Cai, Z., Zhang, W., Yang, F., Yu, L., Zhou, Y., Pan, J., Wang, L., Cao, X., & Wang, J. (2011) · Cell Research · doi:10.1038/cr.2011.196 · Cited by 142
Self-citationFeagan, B. G., Sandborn, W. J., Danese, S., Wolf, D. C., Liu, W. J., Hua, S. Y., Minton, N., Olson, A. D., & D’Haens, G. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30188-6 · Cited by 142
Cellular prion protein is released on exosomes from activated platelets
Robertson, C., Booth, S. A., Beniac, D. R., Coulthart, M. B., Booth, T. F., & McNicol, A. (2006) · Blood · doi:10.1182/blood-2005-02-0802 · Cited by 137
Eichenberger, R. M., Talukder, M. H., Field, M. A., Wangchuk, P., Giacomin, P., Loukas, A. C., & Sotillo, J. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1428004 · Cited by 130
Vitamin D improves inflammatory bowel disease outcomes: Basic science and clinical review
Reich, K. M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i17.4934 · Cited by 127
Risks of Inflammatory Bowel Disease Treatment with Glucocorticosteroids and Aminosalicylates
Curkovic, I., Egbring, M., & Kullak-Ublick, G. A. (2013) · Digestive Diseases · doi:10.1159/000354699 · Cited by 126
Extracellular small heat shock proteins: exosomal biogenesis and function
Reddy, V., Madala, S. K., Trinath, J., & Reddy, G. B. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0856-z · Cited by 124
Zhao, Z., Yu, S., Li, M., Gui, X., & Li, P. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b05614 · Cited by 124
Long‐term effect of tacrolimus therapy in patients with refractory ulcerative colitis
YAMAMOTO, S., Nakase, H., MIKAMI, S., Inoue, S., Yoshino, T., Takeda, Y., Kasahara, K., UENO, S., Uza, N., Kitamura, H., et al. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03764.x · Cited by 115
Haifer, C., Kelly, C. R., Paramsothy, S., Andresen, D. N., Papanicolas, L. E., McKew, G. L., Borody, T. J., Kamm, M. A., Costello, S. P., Andrews, J. M., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320260 · Cited by 113
Effect of oral tacrolimus (FK 506) on steroid‐refractory moderate/severe ulcerative colitis
Högenauer, C., Wenzl, H., Hinterleitner, T. A., & Petritsch, W. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01662.x · Cited by 110
Higgins, P., Skup, M., Mulani, P. M., Lin, J., & Chao, J. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.017 · Cited by 110
Sheng, K., He, S., Sun, M., Zhang, G., Kong, X., Wang, J., & Wang, Y. (2020) · Food & Function · doi:10.1039/d0fo00518e · Cited by 110
Aminosalicylates for induction of remission or response in Crohn's disease
Lim, W. C., & Hanauer, S. B. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008870 · Cited by 110
Ford, A. C., Khan, K. J., Talley, N. J., & Moayyedi, P. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.317 · Cited by 108
Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry
Chaparro, M., Garre, A., Mesonero, F., Rodríguez, C., Acosta, M. B., Martínez-Cadilla, J., Arroyo, M., Manceñido, N., Sierra‐Ausín, M., Vera‐Mendoza, I., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa145 · Cited by 108
Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease
Almradi, A., Hanžel, J., Sedaño, R., Parker, C. E., Feagan, B. G., Ma, C., & Jairath, V. (2020) · BioDrugs · doi:10.1007/s40259-020-00451-w · Cited by 108
Anti-Integrins for the Treatment of Inflammatory Bowel Disease: Current Evidence and Perspectives
Gubatan, J. M. B., Keyashian, K., Rubin, S. J. S., Wang, J., Buckman, C., & Sinha, S. R. (2021) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s293272 · Cited by 105
Methotrexate for induction of remission in ulcerative colitis
Chande, N., Wang, Y., MacDonald, J. K., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006618.pub3 · Cited by 103
Lindsay, J. O., Allez, M., Clark, M., Labopin, M., Ricart, E., Rogler, G., Rovira, M., Satsangi, J., Farge, D., Hawkey, C. J., et al. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(17)30056-0 · Cited by 103
A multi‐centre audit of excess steroid use in 1176 patients with inflammatory bowel disease
Selinger, C. P., Parkes, G. C., Bassi, A., Fogden, E. N., Hayee, B., Limdi, J. K., Ludlow, H., McLaughlin, S. D., Patel, P., Smith, M. A., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14334 · Cited by 103
Balram, B., Battat, R. J., Khoury, A. A., D’Aoust, J., Afif, W., Bitton, A., Lakatos, P. L., & Bessissow, T. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy143 · Cited by 101
Keshteli, A. H., Millan, B., & Madsen, K. L. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.123 · Cited by 98
Urine Exosome Isolation and Characterization
Street, J. M., Koritzinsky, E. H., Glispie, D. M., & Yuen, P. S. T. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7172-5_23 · Cited by 98
Vedolizumab for inflammatory bowel disease: From randomized controlled trials to real-life evidence
Scribano, M. L. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i23.2457 · Cited by 96
Patient Perceptions of Fecal Microbiota Transplantation for Ulcerative Colitis
Kahn, S. A., Vachon, A., Rodriquez, D. M., Goeppinger, S. R., Surma, B. L., Marks, J., & Rubin, D. T. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f520 · Cited by 94
Petit, C. S. V., Barreau, F., Besnier, L., Gandille, P., Riveau, B., Château, D., Roy, M., Berrebi, D. D., Svrcek, M., Cardot, P., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.029 · Cited by 92
Komaki, Y., Komaki, F., Ido, A., & Sakuraba, A. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv221 · Cited by 92
Sandborn, W. J., Vermeire, S., Tyrrell, H. E. J., Hassanali, A., Lacey, S., Tole, S., & Tatro, A. R. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01366-2 · Cited by 92
Ocansey, D. K. W., Wang, L., Wang, J., Yan, Y., Qian, H., Zhang, X., Xu, W., & Mao, F. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0251-8 · Cited by 91
Christensen, B., Gibson, P. R., Micić, D., Colman, R. J., Goeppinger, S. R., Kassim, O., Yarur, A. J., Weber, C. R., Cohen, R. D., & Rubin, D. T. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.060 · Cited by 90
Sandborn, W. J., Danese, S., D’Haens, G., Moro, L., Jones, R., Bagin, R. G., HUANG, M. L., Ballard, E. D., Masure, J. A., & Travis, S. P. L. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13076 · Cited by 89
Yang, X., Song, M., Jiang, H., et al. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.490596 · Cited by 89
van Dieren, J. M., Kuipers, E. J., Samsom, J. N., Nieuwenhuis, E. E. S., & van der Woude, J. C. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000209787.19952.53 · Cited by 87
Coward, S., Kuenzig, M. E., Hazlewood, G. S., Clement, F. M., McBrien, K., Holmes, R. S., Panaccione, R., Ghosh, S. K., Seow, C. H., Rezaie, A. R., et al. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001023 · Cited by 85
Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors
Watanabe, S., Arimura, Y., Nagaishi, K., Isshiki, H., Onodera, K., Nasuno, M., Yamashita, K., Idogawa, M., Naishiro, Y., Murata, M., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0901-3 · Cited by 84
Dore, M. P., Bibbò, S., Fresi, G., Bassotti, G., & Pes, G. M. (2019) · Nutrients · doi:10.3390/nu11122913 · Cited by 83
Antibiotics for induction and maintenance of remission in Crohn's disease
Townsend, C., Parker, C. E., MacDonald, J. K., Nguyen, T. M., Jairath, V., Feagan, B. G., & Khanna, R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012730.pub2 · Cited by 81
Danese, S., & Peyrin‐Biroulet, L. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab135 · Cited by 81
Hematopoietic Stem Cell Homing to Injured Tissues
Kavanagh, D. P. J., & Kalia, N. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9240-z · Cited by 79
Pellet, G., Stéfanescu, C., Carbonnel, F., Peyrin‐Biroulet, L., Roblin, X., Allimant, C., Nachury, M., Nancey, S., Filippi, J., Altwegg, R., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.081 · Cited by 79
CHHAYA, V. A., Saxena, S. K., Cecil, E. V., Subramanian, V., Ćurčin, V., Majeed, A., & Pollok, R. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13700 · Cited by 78
Methotrexate for the treatment of refractory Crohn's disease.
Lémann, M., Chamiot‐Prieur, C., Mesnard, B., Halphen, M., Messing, B., Rambaud, J. C., Jp, G., Colombel, J. F., & Modigliani, R. (1996) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.0953-0673.1996.00309.x · Cited by 76
Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis
Yoshino, T., Nakase, H., Honzawa, Y., Matsumura, K., Yamamoto, S., Takeda, Y., Ueno, S., Uza, N., Masuda, S., Inui, K., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21318 · Cited by 75
Using corticosteroids appropriately in inflammatory bowel disease: a guide for primary care
Barrett, K. J., Saxena, S. K., & Pollok, R. (2018) · British Journal of General Practice · doi:10.3399/bjgp18x699341 · Cited by 75
Efficacy of stem cells therapy for Crohn’s fistula: a meta-analysis and systematic review
Cao, Y., Su, Q., Zhang, B., Shen, F., & Li, S. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02095-7 · Cited by 75
Creed, T., & Probert, C. S. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03156.x · Cited by 73
Gu, P., & Feagins, L. A. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz268 · Cited by 71
Exosome in intestinal mucosal immunity
Xu, A. T., Lu, J. T., Ran, Z. H., & Zheng, Q. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13413 · Cited by 70
Jin, J. O. (2017) · JAMA · doi:10.1001/jama.2016.17822 · Cited by 69
Mediterranean Diet Adherence and Dietary Attitudes in Patients with Inflammatory Bowel Disease
Vrdoljak, J., Vilović, M., Živković, P. M., Hadjina, I. T., Rušić, D., Bukić, J., Borovac, J. A., & Božić, J. (2020) · Nutrients · doi:10.3390/nu12113429 · Cited by 69
Vautrin, A., Manchon, L., Garcel, A., Campos, N., Lapasset, L., Laaref, A. M., Bruno, R., Gislard, M., Dubois, E., Scherrer, D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37813-y · Cited by 68
Mechanism of action of 5‐arninosalicylic acid
Punchard, N. A., Greenfield, S. M., & Thompson, R. P. H. (1992) · Mediators of Inflammation · doi:10.1155/s0962935192000243 · Cited by 66
Yarur, A. J., & Rubin, D. T. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000380 · Cited by 66
Induction of Colonic Regulatory T Cells by Mesalamine by Activating the Aryl Hydrocarbon Receptor
Oh‐oka, K., Kojima, Y., Uchida, K., Yoda, K., Ishimaru, K., Nakajima, S., Hemmi, J., Kano, H., Fujii‐Kuriyama, Y., Katoh, R., et al. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.03.010 · Cited by 66
Gisbert, J. P., Niño, P., Cara, C., & Rodrigo, L. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03732.x · Cited by 65
Stem cell therapy for inflammatory bowel disease
Nagaishi, K., Arimura, Y., & Fujimiya, M. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1040-9 · Cited by 65
Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy
Mishra, R., Dhawan, P., Srivastava, A. S., & Singh, A. B. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i10.1050 · Cited by 63
Angelino, D., Martina, A., Rosi, A., Veronesi, L., Antonini, M., Mennella, I., Vitaglione, P., Grioni, S., Brighenti, F., Zavaroni, I., et al. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz071 · Cited by 62
Cited by
Sic, A., Cvetkovic, K., Manchanda, E., & Knezevic, N. N. (2024) · Diseases · doi:10.3390/diseases12090220 · Cited by 65
Benameur, T., Porro, C., Twfieg, M.-E., Benameur, N., Panaro, M. A., Filannino, F. M., & Hasan, A. (2023) · Brain Sciences · doi:10.3390/brainsci13081226 · Cited by 60
“In the context of intestinal microbiota disorder, researchers have demonstrated some effective treatment methods for IBD through the improvement of intestinal microecology, including the use of prebiotics, probiotics, antibiotics, postbiotics, symbiotics, and FMT [140].”
BackgroundInfluentialLiu, W., Zhang, S., Dong, C., Lv, X., Zheng, X., Zhao, W., Jamali, M., Abedi, R., & Saedisomeolia, A. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-01002-2 · Cited by 9
Metadata
- Authors
- Cai, Z., Wang, S., & Li, J.
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2021-12-20
- Volume
- 8
- Pages
- 765474-765474
- ISSN
- 2296-858X (ISSN-L)
- OpenAlex
- W4200161003
- Cited by
- 675
- References
- 232
- FWCI
- 44.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.